Although it seems an unlikely place to study a psychedelic, Kentucky could be the first state to fund research into ibogaine for the treatment of opioid use disorder.
PsyCon will be at the Colorado Convention Center September 28-29, 2023. The expo, centered around the legal psychedelics space, expects 2,500 visitors.
Experts told state officials on Monday that the biggest risk to using ibogaine is adverse cardiac activity, though those risks can be minimized in a medical setting.